WASHINGTON (Reuters) - Tighter controls are needed on medical tests, biological drugs and private insurance plans to help rein in costs to the U.S. Medicare health insurance program, a panel of advisers said on Monday.
Source: feeds.reuters.com
Labels:
0 comments:
Post a Comment